neelakantan et al. biochemical pharmacology 2019 5-amino-1mq – Y&P Labs 5-Amino-1MQ 50mg

Approach Phase 2b trial arm Duration 24 weeks Review Point Week 12 and 24 Notes METAOD006 (OPTIONS) used 24 weeks at oral doses 0.25, 0.5, or 1 mg/day in 502 obese adults

Success requires physician supervision, objective body composition monitoring (not just scale weight), and integration with proper nutrition and exercise foundations for optimal metabolic outcomes

a small molecule that remains preclinical and not approved

When combined with other fat-burning and metabolism-boosting ingredients, our Skinny B12 Shots become an effective tool in your weight management and wellness plan

This dose usually keeps B12 levels good for most patients

5-Amino-1MQ Side Effects and Safety Questions Because human safety data is limited, the side effect profile of 5-Amino-1MQ is not fully established